The GABAergic Gateway: A Chemist's Hypothesis for Psychedelic Mechanisms
Abstract
<p>Background: Psychedelic-assisted therapies show promise for MDD, PTSD, and addiction, yet mechanisms are often framed as 5-HT2A-centric, despite evidence of GABAergic pathology in these conditions.Hypothesis (Author Perspective): As a chemist examining psychedelic pharmacology, I propose that inhibitory-circuit modulation acts as a necessary systems-level gate converting transient 5-HT2A activation into acute phenomenology and sustained plasticity.Evidence: (i) Provisional 1H-MRS indicates coordinated mPFC GABA-glutamate recalibration (GABA+ denotes macromolecule-containing edited signal; interpretation requires harmonized pipelines); (ii) critical-period reopening (2 days-4 weeks) outlasts receptor occupancy, implicating downstream gating; (iii) target disorders show robust GABAergic deficits.Predictions: This framework suggests ΔGABA+ should couple to network and gamma changes; post-acute GABA_A positive allosteric modulation (PAM) potentiation should truncate plasticity windows; baseline GABA+ may stratify response.Implications: This perspective suggests treating GABA as a potential gate, not the origin, and encourages integrating 7T MRS, PET, TMS-EEG, and pharmacological challenges.Disconfirmers: The hypothesis would be challenged by an absence of ΔGABA+-network coupling; failure of post-acute GABA_A PAMS to truncate plasticity windows; or no prognostic value of baseline GABA+ after harmonized analysis.Note: This hypothesis paper presents a cross-disciplinary perspective intended to stimulate neuroscience research. Empirical validation by systems neuroscience experts is required.</p>
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.